What is the difference between BPC-157 and TB-500 for tendon repair
Linebarger: It works for people who have inflammation
Bedtime administration is strongly recommended because endogenous GH secretion peaks during sleep [3]
The total human evidence base, as of this writing, consists of the following: 1) a Phase I safety trial of 42 healthy volunteers that was registered in 2015, canceled in 2016, and never published, 2) a retrospective case series of 12 patients with knee pain, no control group, and no validated outcome measure, and 3) a 2025 pilot safety study involving two healthy adults who received intravenous infusions at a single private clinic in Florida
The FDA's concerns cite peptide manufacturing risks: incompletely characterised active ingredient, peptide fragments, degradation products, and impurities that the immune system may recognise as foreign
Each batch is tested and verified before it reaches our patients